APA

van Dam M., Zwart M., de Beer F., Smelt A. H. M., Prins M. H., Trip M. D., Havekes L. M., Lansberg P. J. & Kastelein J. J. P. (20020920). Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia. : Heart (British Cardiac Society).

Chicago

van Dam M, Zwart M, de Beer F, Smelt A H M, Prins M H, Trip M D, Havekes L M, Lansberg P J and Kastelein J J P. 20020920. Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia. : Heart (British Cardiac Society).

Harvard

van Dam M., Zwart M., de Beer F., Smelt A. H. M., Prins M. H., Trip M. D., Havekes L. M., Lansberg P. J. and Kastelein J. J. P. (20020920). Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia. : Heart (British Cardiac Society).

MLA

van Dam M, Zwart M, de Beer F, Smelt A H M, Prins M H, Trip M D, Havekes L M, Lansberg P J and Kastelein J J P. Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia. : Heart (British Cardiac Society). 20020920.